Pfizer shares drop 4.5% as Moderna says its vaccine can be stored in fridge
Team Udayavani, Nov 17, 2020, 10:29 AM IST
Pfizer’s shares fell as much as 4.5% on Monday after rival Moderna said its experimental COVID-19 vaccine, which is 94.5% effective, can be stored at normal fridge temperatures of 2-8°C for 30 days and for up to 6 months at -20°C. Pfizer’s vaccine, which is over 90% effective, must be stored at -70°C. Moderna’s stock jumped 10% on the news.
Moderna shares were up 9% after hitting a record high earlier on Monday, while shares in British drugmaker AstraZeneca (AZN.L), which is yet to release results from its late-stage vaccine trials, were down 0.9%.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Sensex, Nifty extend losses into 3rd session on foreign fund outflows; all eyes on US Fed’s decision
Markets decline in early trade amid foreign fund outflows; all eyes on US Fed interest rate decision
MRPL commissions bitumen production unit using cutting-edge technology
DGCA issues show cause notice to Akasa Air on violation related to operations manual
Investors’ wealth down Rs 4.92 lakh crore as markets slump
MUST WATCH
Latest Additions
Assembly clears Mysuru Development Authority Bill
Blocked 18 OTT platforms for publishing obscene, vulgar content: Govt
Boy critically injured after tree branch falls on him in Bengaluru
Congress claims party worker ‘died due to tear gas smoke’ during protest in Assam
Four dead in road accident in Kolar
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.